Home > News > Biophan's CEO takes on new role
May 8th, 2007
Biophan's CEO takes on new role
Biophan Technologies Inc. CEO Michael Weiner has resigned as CEO but will stay on as president and as a director, company officials said Tuesday.
The board has formed an executive committee to oversee the operations of the organization. It includes Weiner, Chairman Guenter Jaensch and Stanley Yakatan, a board member.
"Today's announcement represents the beginning of a series of alterations to the Biophan business designed to bring about positive change," Jaensch said in a statement. "The role of the executive committee will be to transform the company's short-term and long-term goals into management objectives for the staff, and where necessary, implement tactics."
Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Making graphene work for real-world devices: Fundamental research in phonon scattering helps researchers design graphene materials for applications April 24th, 2014
Return on investment for kit and promotion materials April 24th, 2014
Protecting olive oil from counterfeiters April 24th, 2014
High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014